UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
54 hedge funds and large institutions have $153M invested in Unity Biotechnology in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 23 increasing their positions, 11 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
25% less funds holding
Funds holding: 72 → 54 (-18)
63% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 27
Holders
54
Holding in Top 10
3
Calls
$4.15M
Puts
$96K
Top Buyers
| 1 | +$141M | |
| 2 | +$152K | |
| 3 | +$137K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$134K |
| 5 |
FFVM
Founders Fund V Management
San Francisco,
California
|
+$121K |
Top Sellers
| 1 | -$1.69M | |
| 2 | -$1.61M | |
| 3 | -$665K | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$274K |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$240K |